Zobrazeno 1 - 10
of 31
pro vyhledávání: '"A. Zahralliyali"'
Autor:
Esmail Al-Ezzi, Abhenil Mittal, Zachary W. Veitch, Amer Zahralliyali, Nely Mercy Diaz Mejia, Osama Abdeljalil, Husam Alqaisi, Vikaash Kumar, Aaron R. Hansen, Nazanin Fallah-Rad, Srikala S. Sridhar
Publikováno v:
Journal of Kidney Cancer and VHL, Vol 11, Iss 1 (2024)
Immunotherapy (IO) with or without targeted therapy (TT) is the standard treatment for patients with metastatic clear cell renal cell carcinoma (RCC). The evidence supporting their use in metastatic nonclear cell renal cell carcinoma (nccRCC) subtype
Externí odkaz:
https://doaj.org/article/b7d3d94769e84d84a091c0eecef9f662
Autor:
Esmail M. Al-Ezzi, Amer Zahralliyali, Aaron R. Hansen, Robert J. Hamilton, Michael Crump, John Kuruvilla, Lori Wood, Lucia Nappi, Christian K. Kollmannsberger, Scott A. North, Eric Winquist, Denis Soulières, Sebastien J. Hotte, Di Maria Jiang
Publikováno v:
Current Oncology, Vol 30, Iss 7, Pp 6166-6176 (2023)
Background: Although metastatic germ cell tumor (GCT) is highly curable with initial cisplatin-based chemotherapy (CT), 20–30% of patients relapse. Salvage CT options include conventional (CDCT) and high dose chemotherapy (HDCT), however definitive
Externí odkaz:
https://doaj.org/article/cdf6575c6dd6426a9ccb2edad31d8e08
Autor:
Al-Ezzi, Esmail M.1 (AUTHOR) esmail.al-ezzie@uhn.ca, Zahralliyali, Amer1 (AUTHOR) dr.amerzahr84@gmail.com, Hansen, Aaron R.1,2 (AUTHOR), Hamilton, Robert J.3 (AUTHOR), Crump, Michael1 (AUTHOR), Kuruvilla, John1 (AUTHOR), Wood, Lori4 (AUTHOR), Nappi, Lucia5 (AUTHOR), Kollmannsberger, Christian K.5 (AUTHOR), North, Scott A.6 (AUTHOR), Winquist, Eric7 (AUTHOR), Soulières, Denis8 (AUTHOR), Hotte, Sebastien J.9 (AUTHOR), Jiang, Di Maria1 (AUTHOR) di.jiang@uhn.ca
Publikováno v:
Current Oncology. Jul2023, Vol. 30 Issue 7, p6166-6176. 11p. 2 Charts, 4 Graphs.
Autor:
Al-Ezzi, Esmail, Mittal, Abhenil, Veitch, Zachary W., Zahralliyali, Amer, Diaz Mejia, Nely Mercy, Abdeljalil, Osama, Alqaisi, Husam, Kumar, Vikaash, Hansen, Aaron R., Fallah-Rad, Nazanin, Sridhar, Srikala S.
Publikováno v:
Journal of Kidney Cancer & VHL; 2024, Vol. 11 Issue 1, p41-48, 8p
Autor:
Jiang, Esmail M. Al-Ezzi, Amer Zahralliyali, Aaron R. Hansen, Robert J. Hamilton, Michael Crump, John Kuruvilla, Lori Wood, Lucia Nappi, Christian K. Kollmannsberger, Scott A. North, Eric Winquist, Denis Soulières, Sebastien J. Hotte, Di Maria
Publikováno v:
Current Oncology; Volume 30; Issue 7; Pages: 6166-6176
Background: Although metastatic germ cell tumor (GCT) is highly curable with initial cisplatin-based chemotherapy (CT), 20–30% of patients relapse. Salvage CT options include conventional (CDCT) and high dose chemotherapy (HDCT), however definitive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::e8b0ceef8457ec32071ed6f5d12ab154
Autor:
Esmail Mutahar Al-Ezzi, Abhenil Mittal, Zachary William Neil Veitch, Amer Zahralliyali, Nely Mercy Diaz Mejia, Osama Abdeljalil, Husam Alqaisi, Vikaash Kumar, Nazanin Fallah-Rad, Srikala S. Sridhar
Publikováno v:
Journal of Clinical Oncology. 41:636-636
636 Background: Immunotherapy (IO) with or without targeted therapy (TT) is the standard treatment for patients (pts) with advanced clear cell renal cell carcinoma. The evidence to support their use in metastatic non-clear cell renal cell carcinoma (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::714510496686bfa3da09473c65349aaf
https://doi.org/10.1200/jco.2023.41.6_suppl.636
https://doi.org/10.1200/jco.2023.41.6_suppl.636
Autor:
Nely Mercy Diaz Mejia, Carlos Stecca, Di Maria Jiang, Nazanin Fallah-Rad, Philippe L. Bedard, Vikaash Kumar, Osama Abdeljalil, Amer Zahralliyali, Husam Alqaisi, Esmail Mutahar Al-Ezzi, Vivian Choy, Parmvir Banwait, Eshetu Atenafu, Srikala S. Sridhar
Publikováno v:
Journal of Clinical Oncology. 41:115-115
115 Background: To mitigate the risks of chemotherapy associated neutropenia, during the COVID-19 pandemic, all genitourinary (GU) cancer patients treated with chemotherapy at the Princess Margaret Cancer Centre (PMCC) were offered primary prophylaxi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39e9cd07537565af0afa89c3c776d8cb
https://doi.org/10.1200/jco.2023.41.6_suppl.115
https://doi.org/10.1200/jco.2023.41.6_suppl.115
Publikováno v:
International Journal of Advanced Research. 5:1106-1109
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a31f273036af918468a0d7c2b9fc2c9
https://doi.org/10.21474/ijar01/6063
https://doi.org/10.21474/ijar01/6063
Autor:
W Taha AbdelGhafar, A. Zahralliyali, Faisal Azam, Nedal Bukhari, F. Ibnshamsah, W. Alselwi, A. Alwbari
Publikováno v:
ePoster.
Introduction/Background Gestational trophoblastic neoplasia (GTN) constitutes rare group of benign and malignant neoplasia. BHCG (Beta human chorionic gonadotropins) is serum tumor marker that indicates a treatment response. This study is aimed to ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::947d3b92d7fbf7bbe22feef36e8778bc
https://doi.org/10.1136/ijgc-2019-esgo.1175
https://doi.org/10.1136/ijgc-2019-esgo.1175
Publikováno v:
International Journal of Advanced Research. 5:403-405
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d7c967db095ad06f0b2e405eadd9ebe
https://doi.org/10.21474/ijar01/5343
https://doi.org/10.21474/ijar01/5343